Track topics on Twitter Track topics that are important to you
In the Special Communication entitled “FDA Approval and Regulation of Pharmaceuticals, 1983-2018” published in the January 14, 2020, issue of JAMA, a figure legend was missing. Figure 2 should have included a legend that read “Data are from annual Prescription Drug User Fee Act financial reports (1993-2018) and exclude data from other user fee acts. FDA indicates US Food and Drug Administration.” This article was corrected online.
Original Article: Missing Figure LegendNEXT ARTICLE
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...
BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...